OP-based Innovation in Motion angel fund finds sweet spot in seed stage startups
February 1, 2019 | Startland Staff
A financial haven for entrepreneurs with fresh ideas in the agriculture, animal and human health spaces, Innovation in Motion (IIM) has made its ninth angel investment, said Lydia Kinkade.
“We look for companies that are solving big problems, have a stellar team, and are poised to grow quickly,” said Kinkade, the Overland Park-sown fund’s managing director.
With a total of $2.372 million now invested in its portfolio companies, IIM has backed three Kansas City companies on both sides of the border — Mobility Designed, Mazen Animal Health, and Nomi, Kinkade said.
“Our sweet spot is seed stage companies, but we have also invested in Series A and B rounds,” Kinkade explained of the funds investment strategy. “We look for opportunities to be highly engaged with our portfolio companies by facilitating introductions to potential customers and strategic partners, ongoing communication throughout the lifecycle of the company, and sometimes a seat on the company’s board.”
Additionally, IIM has funded companies in Colorado, Iowa, Pennsylvania, and Illinois.
Click here to learn more about IIM’s investment qualifications.
Online since 2013, the firm — founded by Kinkade and serial entrepreneurs behind Overland Park-based Cohen-Esrey, LLC — began making investments in 2015, Kinkade said.
“We took some time to determine our vision and strategy, and [then started investing],” she explained of the funds investment strategy.
In addition to the nine companies in IIM’s current portfolio, the fund has made commitments to two additional companies, Kinkade revealed.
Featured Business
2019 Startups to Watch
stats here
Related Posts on Startland News
In time for Mother’s Day: Ovatemp wants to boost women’s fertility
The arrival of Ana Mayer’s baby girl isn’t the only thing she’ll be thinking about this Mother’s Day. Mayer — who’s among the newest founders in the Techstars-led Sprint Mobile Health Accelerator in Kansas City — will also be mulling how to further develop Ovatemp, the Boston-based ovulation tech company she leads. Ovatemp offers women…
Founder of defunct Symptomly shares lessons from failure
Failure is a touchy subject. But for Derek Bereit — the former CEO and co-founder of mobile asthma tracking company Symptomly — his company’s failure was an opportunity shrouded in a difficult situation. Rather than sulking, Bereit sat down with Startland News to discuss Symptomly’s demise, the lessons it provided him and the possibilities that…